ANVS has 36-month beta value of 1.61. Analysts have mixed views on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for ANVS is 8.14M, and currently, short sellers hold a 18.48% ratio of that float. The average trading volume of ANVS on April 17, 2024 was 241.49K shares.
ANVS) stock’s latest price update
The stock price of Annovis Bio Inc (NYSE: ANVS) has dropped by -9.11 compared to previous close of 11.09. Despite this, the company has seen a fall of -12.27% in its stock price over the last five trading days. Zacks Investment Research reported 2024-04-08 that The average of price targets set by Wall Street analysts indicates a potential upside of 218.9% in Annovis Bio (ANVS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
ANVS’s Market Performance
Annovis Bio Inc (ANVS) has seen a -12.27% fall in stock performance for the week, with a 10.89% gain in the past month and a -14.94% plunge in the past quarter. The volatility ratio for the week is 8.96%, and the volatility levels for the past 30 days are at 9.80% for ANVS. The simple moving average for the past 20 days is -10.93% for ANVS’s stock, with a -6.58% simple moving average for the past 200 days.
Analysts’ Opinion of ANVS
Many brokerage firms have already submitted their reports for ANVS stocks, with Canaccord Genuity repeating the rating for ANVS by listing it as a “Buy.” The predicted price for ANVS in the upcoming period, according to Canaccord Genuity is $36 based on the research report published on December 29, 2023 of the previous year 2023.
Maxim Group, on the other hand, stated in their research note that they expect to see ANVS reach a price target of $150, previously predicting the price at $45. The rating they have provided for ANVS stocks is “Buy” according to the report published on July 07th, 2021.
ANVS Trading at -2.52% from the 50-Day Moving Average
After a stumble in the market that brought ANVS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -55.18% of loss for the given period.
Volatility was left at 9.80%, however, over the last 30 days, the volatility rate increased by 8.96%, as shares surge +7.35% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +0.20% upper at present.
During the last 5 trading sessions, ANVS fell by -12.27%, which changed the moving average for the period of 200-days by -29.26% in comparison to the 20-day moving average, which settled at $11.35. In addition, Annovis Bio Inc saw -46.10% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for ANVS
The total capital return value is set at -4.21. Equity return is now at value -546.40, with -243.15 for asset returns.
Currently, EBITDA for the company is -45.04 million with net debt to EBITDA at 0.13. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.39.
Conclusion
To put it simply, Annovis Bio Inc (ANVS) has had a bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
